Heron Therapeutics, Inc.

HRTX Nasdaq SEC CIK 818033
Follow Heron Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $35.3M −7.8% vs same quarter last year
Net income −$5M +71.4% vs same quarter last year
EPS, diluted −$0.03 +70% vs same quarter last year
Operating cash flow −$794K −159.7% vs same quarter last year
Revenue by quarter
$40.8M
$38.9M
$37.2M
$38.2M
$40.6M
$34.7M
$37.7M
$35.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$300M−$200M−$100M$0$100M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$154.9M−$20M
FY24$144.3M−$14M
FY23$127M−$111M
FY22$107.7M−$182M
FY21$86.3M−$221M
FY20$88.6M−$227.3M
FY19$146M−$204.7M
FY18$77.5M−$178.8M
FY17$30.8M−$197.5M
FY16$1.3M−$173.1M
FY15-−$97.6M
FY14-−$76.4M
FY13-−$55.3M
FY12-−$23.3M
FY11-−$11.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2573.3%−1.6%−12.9%
FY2473.2%−8%−9.7%
FY2348.8%−87.1%−87.4%
FY2249%−162.2%−169%
FY2146.7%−252.3%−255.9%
FY2059.2%−257.4%−256.4%
FY1957.8%−144.3%−140.3%
FY1864.5%−237.4%−230.8%
FY1785.1%−632.4%−641.9%
FY1697.3%−13363.2%−13537.4%
FY15---
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$27.9M
FY24−$24.2M
FY23−$60.3M
FY22−$148.7M
FY21−$206.4M
FY20−$191.6M
FY19−$131.7M
FY18−$201M
FY17−$172.9M
FY16−$137.2M
FY15−$79.6M
FY14−$61.7M
FY13−$42.4M
FY12−$18M
FY11−$8.2M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Heron Therapeutics
  • Healthcare median
−15000%−10000%−5000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearHeron TherapeuticsHealthcare median
FY25−12.9%−30.6%
FY24−9.7%−47%
FY23−87.4%−58%
FY22−169%−80.4%
FY21−255.9%−71.9%
FY20−256.4%−62.2%
FY19−140.3%−46.3%
FY18−230.8%−49.6%
FY17−641.9%−45.9%
FY16−13537.4%−36%
FY15-−38.4%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%